Seeff LB - Search Results

1

Causality assessment for suspected DILI during clinical phases of drug development.

Regev A, Seeff LB, Merz M, Ormarsdottir S, Aithal GP, Gallivan J, Watkins PB. Regev A, et al. Among authors: seeff lb. Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S47-56. doi: 10.1007/s40264-014-0185-4. Drug Saf. 2014. PMID: 25352327 Free PMC article. Review.

2

Drug-induced liver injury: summary of a single topic clinical research conference.

Watkins PB, Seeff LB. Watkins PB, et al. Among authors: seeff lb. Hepatology. 2006 Mar;43(3):618-31. doi: 10.1002/hep.21095. Hepatology. 2006. PMID: 16496329

3

Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.

Rochon J, Protiva P, Seeff LB, Fontana RJ, Liangpunsakul S, Watkins PB, Davern T, McHutchison JG; Drug-Induced Liver Injury Network (DILIN). Rochon J, et al. Among authors: seeff lb. Hepatology. 2008 Oct;48(4):1175-83. doi: 10.1002/hep.22442. Hepatology. 2008. PMID: 18798340 Free PMC article.

4

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop.

Fontana RJ, Seeff LB, Andrade RJ, Björnsson E, Day CP, Serrano J, Hoofnagle JH. Fontana RJ, et al. Among authors: seeff lb. Hepatology. 2010 Aug;52(2):730-42. doi: 10.1002/hep.23696. Hepatology. 2010. PMID: 20564754 Free PMC article.

5

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.

Rockey DC, Seeff LB, Rochon J, Freston J, Chalasani N, Bonacini M, Fontana RJ, Hayashi PH; US Drug-Induced Liver Injury Network. Rockey DC, et al. Among authors: seeff lb. Hepatology. 2010 Jun;51(6):2117-26. doi: 10.1002/hep.23577. Hepatology. 2010. PMID: 20512999 Free PMC article.

6

Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases.

Brinker AD, Wassel RT, Lyndly J, Serrano J, Avigan M, Lee WM, Seeff LB. Brinker AD, et al. Among authors: seeff lb. Hepatology. 2009 Jan;49(1):250-7. doi: 10.1002/hep.22620. Hepatology. 2009. PMID: 19085949

7

HLA-B*35:01 and Green Tea-Induced Liver Injury.

Hoofnagle JH, Bonkovsky HL, Phillips EJ, Li YJ, Ahmad J, Barnhart H, Durazo F, Fontana RJ, Gu J, Khan I, Kleiner DE, Koh C, Rockey DC, Seeff LB, Serrano J, Stolz A, Tillmann HL, Vuppalanchi R, Navarro VJ; Drug-Induced Liver Injury Network. Hoofnagle JH, et al. Among authors: seeff lb. Hepatology. 2021 Jun;73(6):2484-2493. doi: 10.1002/hep.31538. Epub 2021 May 17. Hepatology. 2021. PMID: 32892374 Free PMC article.

8

Diagnosis, management, and treatment of hepatitis C: an update.

Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Ghany MG, et al. Among authors: seeff lb. Hepatology. 2009 Apr;49(4):1335-74. doi: 10.1002/hep.22759. Hepatology. 2009. PMID: 19330875 Free PMC article. No abstract available.

9

National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002.

Seeff LB, Hoofnagle JH. Seeff LB, et al. Hepatology. 2002 Nov;36(5 Suppl 1):S1-2. doi: 10.1053/jhep.2002.36992. Hepatology. 2002. PMID: 12407571 No abstract available.

10

Mortality follow-up of the 1942 epidemic of hepatitis B in the U.S. Army.

Norman JE, Beebe GW, Hoofnagle JH, Seeff LB. Norman JE, et al. Among authors: seeff lb. Hepatology. 1993 Oct;18(4):790-7. doi: 10.1002/hep.1840180407. Hepatology. 1993. PMID: 8406352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page